4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-034348
President and CEO sold 9,930 shares at $17.32 ($171,988)
- President and CEO acquired 9,930 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCarthy Sean A. President and CEO | 2017-09-01 | Option exercise | +9,930 | $0.95 | $9,384 | 14,175 | D |
| McCarthy Sean A. President and CEO | 2017-09-01 | Sale | −9,930 | $17.32 | $171,988 | 4,245 | D |
| Derivatives | |||||||
| McCarthy Sean A. President and CEO | 2017-09-01 | Option exercise · Stock Option (right to buy) | −9,930 | 25,043 | D | ||
| Open-market sales · 9,930 sh · avg $17.32 · $171,988 | |||||||
Loading xslF345X03/doc1.xml…